Proteomic signatures of Alzheimer's disease and Lewy body dementias: A comparative analysis
Alzheimer's & Dementia · 2025-01 · 21 (1)
DOI: 10.1002/alz.14375 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Alzheimer's & Dementia, online erschienen am 23.12.2024. Verfasst von Anna Canal-Garcia und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Lewy Body Disease, Alzheimer Disease, Proteomics, Brain. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Demensfonden, Gamla Tjanarinnor Foundation, Stohnes Stiftelse, Loo och Hans Osterman Foundation, Magnus Berwall Foundation, Längmanska kulturfonden,, Lindhes Advokatbyra foundation, Stiftelsen Längmanska Kulturfonden.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION We aimed to identify unique proteomic signatures of Alzheimer's disease (AD), dementia with Lewy bodies (DLB), and Parkinson's disease dementia (PDD). METHODS We conducted a comparative proteomic analysis of 33 post mortem brains from AD, DLB, and PDD individuals without dementia focusing on prefrontal, cingulate, and parietal cortices, using weighted gene co‐expression network analyses with differential enrichment analysis. RESULTS Network modules revealed hub proteins common to all dementias. Lewy body dementias differed from AD by reduced levels of the autophagy protein p62 ( SQSTM1 ), whereas DLB was distinguished from both AD and PDD by altered TRIM33 and cysteine/glutamate transporter (SLC7A11) across brain regions. An increase in mitochondrial and synaptic proteins was related to better cognition whereas enrichment in the extracellular matrix, complement system, and autophagy proteins was associated with greater cognitive impairment. DISCUSSION Our study offers valuable insights into the network‐based biomarker characterization of molecular signatures of AD, DLB, and PDD. Highlights Reduced levels of the autophagy protein p62 ( SQSTM1 ) differentiated Lewy body dementias from Alzheimer's disease (AD) across multiple brain regions. Dementia with Lewy bodies (DLB) was distinguished from both AD and Parkinson's disease dementia (PDD) by altered TRIM33 and cysteine/glutamate transporter (SLC7A11) levels across brain regions. Key mitochondrial oxidative phosphorylation proteins (e.g., COX7A2, TOMM40L, NDUFV1), and synaptic proteins (e.g., GABRB3, GABRB2, GLUA3, GLUA4, SNAP47, dynamin1) were more abundant in preserved cognitive states. Extracellular matrix proteins and members of the complement system (decorin, biglycan, C4A, C4B) showed a strong positive correlation with cognitive decline.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
- Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden.
- King's College London, Wolfson Centre for Age-Related Diseases, London, UK.
- University of Exeter Medical School, University of Exeter, Exeter, UK.
- Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Neurogeriatrics, Karolinska Institutet, BioClinicum, Stockholm, Sweden.
- Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
ORCID-Profile: Erika Bereczki
Förderung
- Demensfonden, Gamla Tjanarinnor Foundation, Stohnes Stiftelse, Loo och Hans Osterman Foundation, Magnus Berwall Foundation, Längmanska kulturfonden,
- Lindhes Advokatbyra foundation
- Stiftelsen Längmanska Kulturfonden
- Loo och Hans Ostermans Stiftelse för Medicinsk Forskning
- Magnus Bergvalls Stiftelse
- Gun och Bertil Stohnes Stiftelse
- Stiftelsen för Gamla Tjänarinnor
- Demensfonden
Zitieren
APA
Canal-Garcia, A., Branca, R. M., Francis, P. T., Ballard, C., Winblad, B., Lehtiö, J., Nilsson, P., Aarsland, D., Pereira, J. B., & Bereczki, E. (2025). Proteomic signatures of Alzheimer's disease and Lewy body dementias: A comparative analysis. Alzheimer's & Dementia, 21(1). https://doi.org/10.1002/alz.14375
Vancouver
Canal-Garcia A, Branca RM, Francis PT, Ballard C, Winblad B, Lehtiö J, et al. Proteomic signatures of Alzheimer's disease and Lewy body dementias: A comparative analysis. Alzheimer's & Dementia. 2025;21(1). doi:10.1002/alz.14375
BibTeX
@article{CanalGarcia2025,
author = {Canal-Garcia, Anna and Branca, Rui M and Francis, Paul T and Ballard, Clive and Winblad, Bengt and Lehtiö, Janne and Nilsson, Per and Aarsland, Dag and Pereira, Joana B and Bereczki, Erika},
title = {Proteomic signatures of Alzheimer's disease and Lewy body dementias: A comparative analysis},
journal = {Alzheimer's & Dementia},
year = {2025},
volume = {21},
number = {1},
doi = {10.1002/alz.14375}
}
EUVIMED